ACA
ACA
Positions held
Your positionsACA isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-02 · Arcosa, Inc. Announces Commencement of Bondholder Calls
2026-09-30 · Why Arcosa Inc. (ACA) Offers a Merger Arbitrage Opportunity
2026-09-18 · Crawford & Company B (CRD.B) Moves 16.0% Higher: Will This Strength Last?
2026-09-10 · Arcosa Shareholders Approve $8.5B CRH Deal. Does the Vote De-Risk a First-Quarter 2027 Closing?
2026-09-04 · Arcosa Says Shareholders Approved CRH Deal
2026-09-04 · Arcosa Stockholders Approve Acquisition by CRH
2026-09-02 · Arcosa, Inc. Declares Quarterly Dividend
2026-08-17 · Arcosa (ACA) Could Be 1% Undervalued As Valuation Debate Follows Q2 2026 Results
2026-08-17 · Beat the Market the Zacks Way: Bank of America, Marex, Mettler-Toledo International in Focus
2026-08-14 · Chuck Royce's Second Quarter 2026 13F: Catalyst Pharmaceuticals Reduction Leads Portfolio Shifts
2026-08-07 · Can CRH Gain From Its $8.5 Billion Arcosa Deal Despite Financing Risk?
2026-08-07 · CREDIT AGRICOLE SA: Availability of the 2026 interim financial report
Price (daily)
Full chart · RSI · MACD · patterns